title: Perioperative risk factors for haematoma after breast augmentation.
abstract: Postoperative bleeding is the most frequent early complication after breast augmentation. The aim of this retrospective analysis was to assess possible risk factors originating in the perioperative management. All primary, bilateral breast augmentation procedures including augmentation mastopexy performed over an 8-year period were reviewed. Nine cases of postoperative bleeding could be identified in the 132 patients included in the study (6.8%). Univariate statistical analysis revealed age (p < 0.01), the amount of administered fluid intraoperatively (p < 0.05) and within the first 24 hours from the onset of anaesthesia (p < 0.01), the use of colloids (p < 0.01), total intravenous anaesthesia (p < 0.05), and systolic hypotension during the last 30 minutes of the operation (p < 0.05) as risk factors, whereas none of them could be identified as independent risk factor in multivariate analysis. In conclusion, this study was able to identify risk factors originating in the perioperative management that may lead to haematoma formation after breast augmentation.
authors: Department of Plastic and Hand Surgery, Inselspital, University of Bern, Bern, Switzerland.
authors: Pablo
authors: P
authors: Richard
authors: Rolf
authors: R
authors: Huesler
authors: Andrej
authors: A
authors: Banic
authors: Dominique
authors: D
authors: Erni
authors: Jan A
authors: JA
authors: Plock
mesh_terms: D000328:Adult; D019928:Breast Implantation / Q000009:adverse effects / Q000706:statistics & numerical data; D018427:Breast Implants / Q000009:adverse effects* / Q000706:statistics & numerical data*; D015984:Causality; D004954:Esthetics; D005260:Female; D006406:Hematoma / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D015994:Incidence; D016462:Mammaplasty / Q000009:adverse effects* / Q000706:statistics & numerical data*; D015999:Multivariate Analysis; D012086:Reoperation; D012189:Retrospective Studies; D012307:Risk Factors; D015626:Tissue Expansion / Q000009:adverse effects / Q000706:statistics & numerical data